Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Physical Review. E|October 24, 2019
Dynamics of a grain-scale intruder in a two-dimensional granular medium with and without basal frictionRyan Kozlowski, C Manuel Carlevaro, Karen E Daniels, et al.
Journal of Clinical Pharmacology|July 11, 2025
Characterizing Cellular Expansion of Idecabtagene Vicleucel and Association with Clinical Efficacy and Safety in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple MyelomaFan Wu, Xirong Zheng, Joseph Burnett, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 19, 2016
Model-Based Characterization of the Pharmacokinetics of Pembrolizumab: A Humanized Anti-PD-1 Monoclonal Antibody in Advanced Solid TumorsM Ahamadi, T Freshwater, M Prohn, et al.
Nano Letters|December 31, 2013
Hierarchical nanoparticle ensembles synthesized by liquid phase directed self-assemblyJ D Fowlkes, N A Roberts, Y Wu, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 23, 2016
Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With MelanomaR de Greef, J Elassaiss-Schaap, M Chatterjee, et al.
Journal of Pharmacokinetics and Pharmacodynamics|December 20, 2024
Novel endpoints based on tumor size ratio to support early clinical decision-making in oncology drug-developmentShubhadeep Chakraborty, Kshitij Aggarwal, Marzana Chowdhury, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|February 7, 2014
A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton modelK Melissa Hallow, Arthur Lo, Jeni Beh, et al.
Clinical Pharmacology and Therapeutics|December 31, 2025
Bridging the Gap: Integrating Quantitative Systems Pharmacology and Pharmacometrics in Drug DevelopmentGeorgi I Kapitanov, Justin C Earp, Kapil Gadkar, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 30, 2016
Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab-Treated Advanced MelanomaM S Chatterjee, J Elassaiss-Schaap, A Lindauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2018
Pembrolizumab Exposure-Response Assessments Challenged by Association of Cancer Cachexia and Catabolic ClearanceDavid C Turner, Anna G Kondic, Keaven M Anderson, et al.
Pageof 11